Friday , March 23 2018
Home / Resources / Polls (page 12)


SGLT-2 Recommendations

Since recent developments in the use of SGLT-2 inhibitors, are you positive or negative in recommending to your patients? Follow the link to respond.

Read More »

Switching to Basaglar

Will you consider switching over your Lantus users to Lilly’s new basal insulin Basaglar, which is not approved as a biosimilar product, but has the same exact properties as Lantus and will likely be less expensive? (follow link to respond)

Read More »

Treatment Preference

Of the new medications for type 2 patients, which one do you prefer most for an overweight type 2 patient with an A1c of 8.5% after putting them on metformin? Follow the link to respond.

Read More »